ContextVision to Highlight its World-Leading Ultrasound Product Portfolio at ISUOG 2017
Visit booth #35 at ISUOG’s 27th World Congress in Ultrasound Obstetrics and Gynecology, 16–19 September, Vienna, Austria. ContextVision will be demonstrating their world-leading image enhancement and rendering software for ultrasound.
STOCKHOLM – September 06, 2017 – ContextVision’s state-of-the-art product portfolio for 2D/3D/4D ultrasound will be showcased at ISUOG’s 27th World Congress in Ultrasound Obstetrics and Gynecology, taking place in Vienna next week.
Experienced application specialists will be on site to demonstrate how ContextVision’s advanced software, when integrated with ultrasound products from leading manufacturers, provides clinicians with unsurpassed image quality.
Products to be highlighted include:
US PLUSView™ 2.0 is ContextVision’s fifth generation 2D enhancement product and the world’s leading 2D image enhancement for the entire range of clinical applications. A doctors’ interface, enabling ultrasound manufacturers to adjust image quality according to customer preferences, is now available. The US PLUSView tuning tool offers OEMs flexibility and control over parameter optimization to satisfy various image preferences.
GOPiCE 2.0 is the second generation of ContextVision’s unique 3D/4D ultrasound image enhancement software, providing OEMs with the best image quality available today. Its intelligent processing and sophisticated filtering ensure consistent quality and superior performance.
REALiCE® is ContextVision’s versatile visualization software, built to present fetuses in never-before-seen 3D/4D clarity. True-to-data rendering technology provides unique views of anatomies in early fetal diagnosis. A versatile set of 3D tools allow for accurate and reliable ultrasound imaging.
“The clinical value that our technology brings to the ultrasound market is significant. We continue to be the world’s leading company within image processing, providing software solutions for ultrasound manufacturers globally. This in turn arms clinicians with more detailed real-time information, helping them make accurate and fast diagnoses,” says ContextVision’s Vice President, Fredrik Palm.
ContextVision is a medical technology company specializing in image analysis and artificial intelligence. Its cutting-edge technology helps doctors accurately interpret medical images, a crucial foundation for better diagnosis and treatment. An industry pioneer for more than 30 years, ContextVision is taking a leading position within deep learning, the latest artificial intelligence technology, and is investing significantly in the field to expand the company’s product portfolio. The present product portfolio includes state-of-the-art image enhancement software for 2D/3D/4D ultrasound, MRI, X-ray and mammography which is used by leading equipment manufacturers worldwide. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV. For more information, please visit www.contextvision.com.